Air Products & Chemicals, Inc. : Expect the comeback of a strong trend
Entry price | Target | Stop-loss | Potential |
---|
$276.74 |
$325 |
$262 |
+17.44% |
---|
The price of Air Products & Chemicals, Inc. shares is range-bound. This phase will end sooner or later when volatility comes back.
Summary● The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
● Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses● The company is in debt and has limited leeway for investment
● With a 2023 P/E ratio at 25.48 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
● Based on current prices, the company has particularly high valuation levels.
● In relation to the value of its tangible assets, the company's valuation appears relatively high.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.